Stem cells injected for lung scarring: early trial begins
NCT ID NCT07359963
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial will test a stem cell product called REGEND007 in 12 people with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The stem cells are given through an IV, and the main goal is to check safety and find the right dose. Researchers will also watch for any signs that lung function improves over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- REGEND007 (airway basal layer stem cell preparation)
- What this could lead to
- If successful, this could point toward a new treatment for idiopathic pulmonary fibrosis, a serious lung disease with few options.
- What could go wrong
- This is a very early, small trial (12 people) testing only safety and dosing. It may not show any benefit, and stem cell therapies carry risks like infusion reactions or unknown long-term effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Fourth Hospital of Zhejiang University School of Medicine
Yiwu, Zhejiang, 322000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow lung scarring in IPF?
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease
- Can a new drug slow lung scarring in IPF?
- Blood tests could unlock early clues for three major lung diseases
- AI could uncover hidden lung disease in routine chest X-Rays
- Inhaled drug could offer new hope for lung scarring disease